Mainz Biomed N.V. (MYNZ)

Precedente Chiudi:

$0.66

Aprire:

$0.68

Volume 24 ore:

37,759

Capitalizzazione di mercato:

$14.66M

Reddito:

$895.50K

Utile/perdita netta:

$-26.30M

Rapporto P/E:

-0.3508

EPS:

-1.91

Flusso di cassa netto:

$-23.84M

1 W Prestazione:

-9.46%

1M Prestazione:

-30.93%

6M Prestazione:

-44.17%

1 anno Prestazione:

-87.09%

Intervallo 1D:

$0.6651

$0.70

Portata 52W:

$0.6437

$6.00

Mainz Biomed N.V. Stock (MYNZ) Company Profile

Nome

Mainz Biomed N.V.

Settore

Healthcare (1214)

Industria

Diagnostics & Research (67)

Telefono

49 6131 554 2860

Indirizzo

Robert Koch Strasse 50, Mainz

Dipendente

0

Cinguettio

Prossima data di guadagno

2024-05-31

Ultimi documenti SEC

MYNZ's Discussions on Twitter

Mainz Biomed N.V. Borsa (MYNZ) Ultime notizie

Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.

GlobeNewswire Inc.

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

GlobeNewswire Inc.

Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Mainz Biomed Reports Full Year 2023 Financial Results

GlobeNewswire Inc.

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment

GlobeNewswire Inc.

Mainz Biomed N.V. Azioni (MYNZ) Dati Finanziari

Mainz Biomed N.V. (MYNZ) Reddito 2024

Mainz Biomed N.V. (MYNZ) Reddito netto 2024

Mainz Biomed N.V. (MYNZ) Flusso di cassa 2024

Mainz Biomed N.V. (MYNZ) Utile per azione 2024